Skip to main content

4 Result(s)

within E. A. Woltering Remove this filter

and

  1. No Access

    Article

    Enterostatin inhibition of angiogenesis: possible role of pAMPK and vascular endothelial growth factor A (VEGF-A)

    We utilized a genomic analysis of the response of neuronal GT1-7 cells to enterostatin to identify pathways responsive to this peptide. This information, together with reported properties of the enterostatin r...

    M Park, J Lyons III, H Oh, Y Yu, E A Woltering… in International Journal of Obesity (2008)

  2. Article

    Open Access

    Growing vascular endothelial cells express somatostatin subtype 2 receptors

    We hypothesized that non-proliferating (quiescent) human vascular endothelial cells would not express somatostatin receptor subtype 2 (sst 2) and that this receptor would be expressed when the endothelial cell...

    J C Watson, D A Balster, B M Gebhardt, T M O’Dorisio… in British Journal of Cancer (2001)

    Download PDF (990 KB)

  3. No Access

    Article

    Consensus statement: Octreotide dose titration in secretory diarrhea

    Octreotide is an effective therapeutic option in controlling secretory diarrhea of varied etiology. However, marked patient-to-patient differences in the antidiarrheal effects necessitate titration of octreoti...

    A. G. Harris, Dr. T. M. O'Dorisio, E. A. Woltering… in Digestive Diseases and Sciences (1995)

  4. No Access

    Chapter and Conference Paper

    Tumors of the Gastroenteropancreatic Axis

    VIPomas (VIP: vasoactive intestinal peptide), gastrinomas, glucagonomas, insulinomas and GRFomas (GRF: growth hormone releasing factor) comprise the tumors of the gastroenteropancreatic (GEP) system. Patients ...

    T. S. Gaginella, T. M. O’Dorisio… in Sandostatin® in the Treatment of Gastroent… (1989)